Catalyst Wire Dossier Catalyst Wire Dossier

Raphamin

Raphamin · Materia Medica Holding
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Raphamin, covering 2024-10-15 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients [Phase 3]

See pricing